Butyrylcholinesterase anticorps
Aperçu rapide pour Butyrylcholinesterase anticorps (ABIN2855004)
Antigène
Voir toutes Butyrylcholinesterase (BCHE) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain
-
Attributs du produit
-
Rabbit Polyclonal antibody to BCHE (butyrylcholinesterase)
BCHE antibody [N1N3] -
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the center region of human BCHE. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:10000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: Jurkat , Raji , human BCHE-transfected 293T
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.27 mg/mL
-
Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Butyrylcholinesterase (BCHE)
-
Autre désignation
- butyrylcholinesterase
-
Sujet
-
Mutant alleles at the BCHE locus are responsible for suxamethonium sensitivity. Homozygous persons sustain prolonged apnea after administration of the muscle relaxant suxamethonium in connection with surgical anesthesia. The activity of pseudocholinesterase in the serum is low and its substrate behavior is atypical. In the absence of the relaxant, the homozygote is at no known disadvantage.
-
Poids moléculaire
- 68 kDa
-
ID gène
- 590
-
UniProt
- P06276
-
Pathways
- Peptide Hormone Metabolism
Antigène
-